OSAGI Home Gender Mainstreaming Focal Point

GENDER MAINSTREAMING MANDATES:
HEALTH STATISTICS

Beijing Platform for Action (1995)

104. Statistical data on health are often not systematically collected, disaggregated and analyzed by age, sex and socio-economic status and by established demographic criteria used to serve the interests and solve the problems of subgroups, with particular emphasis on the vulnerable and marginalized and other relevant variables. Recent and reliable data on the mortality and morbidity of women and conditions and diseases particularly affecting women are not available in many countries. Relatively little is known about how social and economic factors affect the health of girls and women of all ages, about the provision of health services to girls and women and the patterns of their use of such services, and about the value of disease prevention and health promotion programmes for women. &

109. By Governments, the United Nations system, health professions, research institutions, non-governmental organizations, donors, pharmaceutical industries and the mass media, as appropriate:

(a) Train researchers and introduce systems that allow for the use of data collected, analyzed and disaggregated by, among other factors, sex and age, other established demographic criteria and socio-economic variables, in policy-making, as appropriate, planning, monitoring and evaluation;

Commission on the Status of Women (1999):
Agreed Conclusions on Women and Health

5. (c) Improve the collection, use and dissemination of data disaggregated by sex and age, and research findings, and develop collection methodologies that capture the differences between women's and men's life experiences, including through the use and, where necessary, further coordinated development of gender-specific qualitative and quantitative health indicators that go beyond morbidity, mortality and social indicators, capturing quality of life, social as well as mental well-being of women and girls;

(i) Ensure, where indicated, that clinical trials of pharmaceuticals, medical devices and other medical products include women with their full knowledge and consent and ensure that the resulting data is analyzed for sex and gender differences;

(j) Collect data concerning scientific and legal developments on human genome and related genetic research and their implications for women's health and women's rights in general and disseminate such information and results of studies conducted in accordance with accepted medical ethical standards.

Beijing +5:
Recommendations of the Ad Hoc Committee of the Whole of the twenty-third special session of the General Assembly (2000)

72. (d) Collect and disseminate updated and reliable data on mortality and morbidity of women and conduct further research regarding how social and economic factors affect the health of girls and women of all ages, as well as research about the provision of health-care services to girls and women and the patterns of use of such services and the value of disease prevention and health promotion programmes for women;

80. Develop and use frameworks, guidelines and other practical tools and indicators to accelerate gender mainstreaming, including gender-based research, analytical tools and methodologies, training, case studies, statistics and information.

92. (c) In partnership, as appropriate, with relevant institutions, promote, improve, systemize and fund the collection of data disaggregated by sex, age and other appropriate factors, on health and access to health services, including comprehensive information on the impact of HIV/AIDS on women, throughout the life-cycle;

(d) Eliminate gender biases in bio-medical, clinical and social research, including by conducting voluntary clinical trials involving women, with due regard for their human rights, and in strict conformity with internationally accepted legal, ethical, medical, safety, and scientific standards, and gather, analyze and make available to appropriate institutions and to end-users gender-specific information about dosage, side-effects and effectiveness of drugs, including contraceptives and methods that protect against sexually transmitted infections.

 
OSAGI Home

Focal Point for Women.

Gender Mainstreaming IANWGE Contact
Office of the Special Adviser on Gender Issues and Advancement of Women (OSAGI)
 
United Nations, Two United Nations Plaza,
44th St. 12th Floor, NY ,NY 10017
URL: http://www.un.org/osagi